ANI Pharmaceuticals, Inc. Balance Sheet
ANIP / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
ANI Pharmaceuticals, Inc. had $1.4B in total assets and $541M in shareholders' equity as of FY2025. Total debt was $292M against $286M in cash, resulting in $6M net debt.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $285.6M | $144.9M | $221.1M | $48.2M | $100.3M | $7.9M | $62.3M | $43.0M | $31.1M | $27.4M | $11.1M | $169.0M | $11.0K | $11.0K | $0 |
| Accounts Receivable | $281.1M | $221.7M | $162.1M | $165.4M | $128.5M | $95.8M | $72.1M | $64.8M | $58.8M | $45.9M | $21.9M | $17.3M | $12.5M | $5.4M | - |
| Inventory | $143.1M | $136.8M | $111.2M | $105.4M | $81.7M | $60.8M | $48.2M | $40.5M | $37.7M | $26.2M | $13.4M | $7.5M | $3.5M | $2.8M | - |
| Current Assets | $753.1M | $528.5M | $519.8M | $344.3M | $321.8M | $170.3M | $187.7M | $152.9M | $131.6M | $103.0M | $192.6M | $195.0M | $27.7M | $8.6M | $58.0M |
| PP&E (Net) | $62.5M | $56.9M | $44.6M | $43.2M | $52.7M | $41.3M | $40.6M | $38.1M | $20.4M | $11.0M | $7.1M | $5.2M | $4.5M | $4.9M | $861.4K |
| Goodwill | $62.5M | $60.0M | $28.2M | $28.2M | $27.9M | $3.6M | $3.6M | $3.6M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $0 | - |
| Total Assets | $1.4B | $1.3B | $904.4M | $760.1M | $771.6M | $461.2M | $456.8M | $430.6M | $412.1M | $322.9M | $285.3M | $259.6M | $44.5M | $13.7M | $62.4M |
| Current Liabilities | $278.1M | $194.5M | $145.5M | $99.4M | $87.5M | $78.6M | $61.7M | $165.5M | $39.2M | $31.9M | $11.8M | $13.2M | $3.5M | $7.7M | $7.2M |
| Total Debt | $291.8M | $309.1M | $284.8M | $285.7M | $286.5M | $172.4M | $175.8M | $67.3M | $128.2M | $120.6M | $113.4M | $106.5M | - | - | - |
| Shareholders' Equity | $540.7M | $403.7M | $432.7M | $313.7M | $333.9M | $195.7M | $212.8M | $197.3M | $174.8M | $169.6M | $41.0M | $139.8M | -$42.7M | -$42.7M | -$34.3M |